Man suffers prolonged erection after drinking energy drink

A Zambian firm said Wednesday it had suspended production of an energy drink after a consumer in Uganda complained of a prolonged erection, with tests suggesting it contained the active ingredient of Viagra. SX Energy Natural Power drink, produced by Revin Zambia, is exported around the region including to Uganda, where the consumer also complained of profuse sweating. Revin Zambia general manager Vikas Kapoor said his company stopped making the drink on Tuesday while launching

countinue reading

Viagra tablets and cash siezed in CAB Raids

The Criminal Assets Bureau (CAB) have carried out eight searches in Co Monaghan as part of a garda operation on an organised crime gang. Assisted by the Emergency Response Unit (ERU), six searches were carried out at residential addresses and two at professional addresses today. A sum of cash in sterling and euro, worth approximately €10,000, was seized. A quantity of documents and electronic devices including mobile phones were seized for analysis. Viagra tablets were

countinue reading

Unichem Labs gets tentative USFDA nod for Tadalafil tablets

Drug firm Unichem Laboratories Tuesday said it has received a tentative nod from the US health regulator for generic Tadalafil tablets used for treatment of erectile dysfunction. The company has received the tentative approval from the United States food and Drug Administration for its Tadalafil tablets in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, Unichem Laboratories said in a filing to the BSE. The tablets are used for treatment of

countinue reading

Lupin gets tentative USFDA nod for generic Tadalafil tablets

Lupin on Monday said it has received tentative approval from the US health regulator for Tadalafil tablets, used to treat erectile dysfunction and enlarged prostate, in the American market. The company has received approval from the US Food and Drug Administration (USFDA) to market its product which is a generic version of Eli Lilly and Company’s Adcirca tablets. According to IQVIA MAT September data, Adcirca tablets, 20 mg, had annual sales of around $ 503.8

countinue reading

Adamis Pharmaceuticals Submits New Drug Application for Tadalafil Sublingual Tablet

Adamis Pharmaceuticals Corporation  today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its fast-dissolving sublingual tadalafil tablet.  This product candidate is designed for the treatment of erectile dysfunction.  Adamis submitted the NDA pursuant to Section 505(b)(2) of the Food, Drug & Cosmetic Act. Tadalafil (Cialis®) is a drug used for treating erectile dysfunction (ED), pulmonary hypertension and benign prostatic hyperplasia (BPH).  Tadalafil is in a

countinue reading